In November of 2020, we discussed the first clinical data for the Monoclonal Antibodies Bamlanivimab and Regenergon (mAb). For a refresher, you can check out the article here. Since that time, researchers have developed several different versions with varying…
Lately, I have been asked numerous times for my opinion on COVID-19 vaccines for pregnant women. While I try not to give my opinion, I base recommendations on currently available evidence. I recommend anyone pregnant or looking to become…
In mid-August, the Food and Drug Administration amended the emergency use authorizations for Pfizer and Moderna to allow a third dose of their COVID-19 vaccines for certain immunocompromised people The CDC now recommends a booster for those who received…
SARS-CoV-2 is a positive-sense single-stranded RNA virus. Being a single-stranded RNA virus, it is unstable and vulnerable to frequent mutations. There have been over 1.8 MILLION SARS-CoV-2 mutated strains identified and entered into the GISAID database. Fortunately, not every…
REMAP-CAP and RECOVERY trials...a little background... So, the REMAP-CAP study published on January 9th set out to determine if the IL-6 receptor antagonists, tocilizumab and Sarilumab, compared with standard care, improve respiratory and cardiovascular organ support free days up…